Cargando…

Microglia-targeting nanotherapeutics for neurodegenerative diseases

Advances in nanotechnology have enabled the design of nanotherapeutic platforms that could address the challenges of targeted delivery of active therapeutic agents to the central nervous system (CNS). While the majority of previous research studies on CNS nanotherapeutics have focused on neurons and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Nanxia, Francis, Nicola L., Calvelli, Hannah R., Moghe, Prabhas V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AIP Publishing LLC 2020
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481010/ https://www.ncbi.nlm.nih.gov/pubmed/32923843 http://dx.doi.org/10.1063/5.0013178

Ejemplares similares

Antioxidant Nanoparticles for Concerted Inhibition of α-Synuclein Fibrillization, and Attenuation of Microglial Intracellular Aggregation and Activation
por: Zhao, Nanxia, et al.
Publicado: (2020)

Nanotherapeutics Containing Lithocholic Acid-Based Amphiphilic Scorpion-Like Macromolecules Reduce In Vitro Inflammation in Macrophages: Implications for Atherosclerosis
por: Moretti, Alysha, et al.
Publicado: (2018)

Engineering Tumor-Targeting Nanoparticles as Vehicles for Precision Nanomedicine
por: Gonda, Amber, et al.
Publicado: (2019)

Targeting mechanisms in cognitive training for neurodegenerative diseases
por: Venneri, Annalena, et al.
Publicado: (2020)

Extracellular Vesicle Molecular Signatures Characterize Metastatic Dynamicity in Ovarian Cancer
por: Gonda, Amber, et al.
Publicado: (2021)

Targeting glial metabolism in neurodegenerative diseases: detail matters
por: Afridi, Ruqayya, et al.
Publicado: (2023)

Targeted nanotherapeutics in cancer
por: Shiekh, Farooq A
Publicado: (2014)

Nuclear sphingomyelin in neurodegenerative diseases
por: Albi, Elisabetta, et al.
Publicado: (2021)

Free ubiquitin: a novel therapeutic target for neurodegenerative diseases
por: Park, Chul-Woo, et al.
Publicado: (2021)

Microglia in neurodegenerative diseases
por: Xu, Yu, et al.
Publicado: (2020)

Nanotherapeutic and Stem Cell Therapeutic Strategies in Neurodegenerative Diseases: A Promising Therapeutic Approach
por: Wei, Min, et al.
Publicado: (2023)

Targeting the epigenome to treat neurodegenerative diseases or delay their onset: a perspective
por: Coppedè, Fabio
Publicado: (2022)

ATP-binding cassette transporters as possible targets for the intervention of neurodegenerative diseases
por: Lok, Hiu Chuen, et al.
Publicado: (2023)

Abnormal metal homeostasis as a common drug target to combat neurodegenerative diseases
por: Pretsch, Dagmar
Publicado: (2021)

Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
por: Gao, Chao, et al.
Publicado: (2023)

A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Nanotherapeutics
por: Lamptey, Richard N. L., et al.
Publicado: (2022)

ZnO nanotherapeutics for the treatment of burn wounds: recent advances: Correspondence
por: Hemmami, Hadia, et al.
Publicado: (2023)

Tayloring cell populations for neurodegenerative diseases
por: Fortin, Jeff M., et al.
Publicado: (2016)

Significance of intercellular communication for neurodegenerative diseases
por: Cihankaya, Hilal, et al.
Publicado: (2021)

Overcoming mitochondrial dysfunction in neurodegenerative diseases
por: Pessoa, João, et al.
Publicado: (2022)

Exercise, microglia, and beyond – workout to communicate with microglia
por: Andoh, Megumi, et al.
Publicado: (2020)

Targeted Nanotherapeutics for Respiratory Diseases: Cancer, Fibrosis, and Coronavirus
por: Majumder, Joydeb, et al.
Publicado: (2020)

Neutrophils and Macrophages as Targets for Development of Nanotherapeutics in Inflammatory Diseases
por: Su, Yujie, et al.
Publicado: (2020)

Nanotherapeutics: Engineering Cell Membrane‐Based Nanotherapeutics to Target Inflammation (Adv. Sci. 15/2019)
por: Yan, Huize, et al.
Publicado: (2019)

Impact of the metabolic syndrome on the evolution of neurodegenerative diseases
por: de A. Boleti, Ana Paula, et al.
Publicado: (2020)

Polyglutamine diseases: looking beyond the neurodegenerative universe
por: Mielcarek, Michal, et al.
Publicado: (2020)

Insights into the protective role of immunity in neurodegenerative disease
por: Comi, Cristoforo, et al.
Publicado: (2017)

Protection against neurodegenerative disease on Earth and in space
por: Takamatsu, Yoshiki, et al.
Publicado: (2016)

Effects of Ketogenic Diet on Neuroinflammation in Neurodegenerative Diseases
por: Jiang, Ziying, et al.
Publicado: (2022)

Therapeutic potential of lysosomal cathepsins for neurodegenerative diseases
por: Prieto Huarcaya, Susy, et al.
Publicado: (2022)

Enterovirus infection and its relationship with neurodegenerative diseases
por: Sousa, Ivanildo Pedro, et al.
Publicado: (2023)

Phenomic Microglia Diversity as a Druggable Target in the Hippocampus in Neurodegenerative Diseases
por: Lana, Daniele, et al.
Publicado: (2023)

Aged Microglia in Neurodegenerative Diseases: Microglia Lifespan and Culture Methods
por: Yoo, Hyun-Jung, et al.
Publicado: (2022)

Nanotherapeutics for treating coronavirus diseases
por: Gunathilake, Thennakoon M. Sampath U., et al.
Publicado: (2021)

The Role of Microglia in the Development of Neurodegenerative Diseases
por: Lee, Jae-Won, et al.
Publicado: (2021)

Microglia Phenotypes in Aging and Neurodegenerative Diseases
por: Wendimu, Menbere Y., et al.
Publicado: (2022)

Dopaminergic mediation in the brain aging and neurodegenerative diseases: a role of senescent cells
por: Nekrasov, Pavel V., et al.
Publicado: (2018)

Disease-associated oligodendrocyte signatures in neurodegenerative disease: the known and unknown
por: Schuster, Kristen H., et al.
Publicado: (2023)

Therapeutic induction of autophagy to modulate neurodegenerative disease progression
por: Hochfeld, Warren E, et al.
Publicado: (2013)

Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases
por: Vance, Jean E.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_7lkneo8hficlpi6kh12uropbp5